WITHDRAWN: Inhaled bronchodilators for cystic fibrosis
- PMID: 26866910
- PMCID: PMC10658835
- DOI: 10.1002/14651858.CD003428.pub3
WITHDRAWN: Inhaled bronchodilators for cystic fibrosis
Abstract
This review has been withdrawn because it has been split into the following reviews: 'Long‐acting inhaled bronchodilators for cystic fibrosis' and 'Short‐acting inhaled bronchodilators for cystic fibrosis'.
The editorial group responsible for this previously published document have withdrawn it from publication.
Update of
-
Inhaled bronchodilators for cystic fibrosis.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003428. doi: 10.1002/14651858.CD003428.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2016 Feb 11;2:CD003428. doi: 10.1002/14651858.CD003428.pub3. PMID: 16235319 Updated.
Similar articles
-
Inhaled bronchodilators for cystic fibrosis.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003428. doi: 10.1002/14651858.CD003428.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2016 Feb 11;2:CD003428. doi: 10.1002/14651858.CD003428.pub3. PMID: 16235319 Updated.
-
Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet).Pediatr Pulmonol. 2000 Mar;29(3):169-71. doi: 10.1002/(sici)1099-0496(200003)29:3<169::aid-ppul2>3.0.co;2-0. Pediatr Pulmonol. 2000. PMID: 10686035 No abstract available.
-
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.Respir Med. 1996 Sep;90(8):497-9. doi: 10.1016/s0954-6111(96)90178-x. Respir Med. 1996. PMID: 8869445 Clinical Trial. No abstract available.
-
Salmeterol and inhaled corticosteroids in patients with persistent asthma.JAMA. 2001 Dec 26;286(24):3076; author reply 3077-8. JAMA. 2001. PMID: 11754664 No abstract available.
-
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006101. doi: 10.1002/14651858.CD006101. Cochrane Database Syst Rev. 2006. PMID: 16856113 Free PMC article.
Cited by
-
Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.Antibiotics (Basel). 2021 Apr 23;10(5):486. doi: 10.3390/antibiotics10050486. Antibiotics (Basel). 2021. PMID: 33922413 Free PMC article. Review.
-
Short-acting inhaled bronchodilators for cystic fibrosis.Cochrane Database Syst Rev. 2022 Jun 24;6(6):CD013666. doi: 10.1002/14651858.CD013666.pub2. Cochrane Database Syst Rev. 2022. PMID: 35749226 Free PMC article.
-
Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.J Bras Pneumol. 2017 May-Jun;43(3):219-245. doi: 10.1590/S1806-37562017000000065. J Bras Pneumol. 2017. PMID: 28746534 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical